市场调查报告书
商品编码
1522702
全球接骨植入物市场:按产品类型、材料、骨折类型、最终用户和地区进行预测(~2032 年)Global Osteosynthesis Implants Market Research Report Information By Product, By Material, By Fracture Type, By End User and by Region - Forecast till 2032 |
预计骨缝合植入物市场规模将从2023年的54亿美元和2024年的56.7亿美元成长到2032年的96.6亿美元,预测期内复合年增长率为6.11%。
推动全球接骨植入物市场成长的两个主要因素是全球骨折率上升和骨质疏鬆症。儘管与骨合成植入物相关的一些课题预计也会限制全球市场的扩张,但正在进行的临床试验、技术突破和全球人口老化预计将使市场有利可图。
骨量减少和脆性增加是骨质疏鬆症的标誌,并对骨折治疗提出了重大课题。骨折在骨质疏鬆症患者中很常见,尤其是髋部、脊椎和手腕等承重骨。骨质疏鬆性骨骼中的骨折通常会带来特殊问题,因为受损骨骼的品质会降低且其机械稳定性也会降低。骨接合植入物对于骨质疏鬆患者的骨折治疗至关重要,因为它们可以提供机械支撑并促进骨折癒合。
随着全球骨质疏鬆症盛行率的增加,对骨缝合植入物的需求也增加。根据International Osteoporosis Foundation预测,2019年全球可能有5亿男性和女性受到骨质疏鬆的影响,每三秒就有一人因骨质疏鬆而骨折。
区域视角
预计2022年北美地区占比将达39.76%,复合年增长率为6.33%,2032年达39.8亿美元。同时,欧洲预计在预测期内将以 7.35% 的最高复合年增长率成长。
北美接骨植入物市场预计将稳定发展,前景依然乐观。该市场的驱动因素包括创伤和运动伤害的高发生率、骨科手术数量的增加以及一流的医疗基础设施和服务。
由于多种因素,包括运动伤害的增加、骨质疏鬆症盛行率的增加以及患者对手术干预益处的认识不断提高,欧洲市场目前正在迅速扩张。
亚太地区预计在预测期内复合年增长率为 5.13%,2022 年为 9.9 亿美元。世界其他地区预计将从 2022 年的 7.1 亿美元开始成长,在预测期内复合年增长率为 2.76%。
本报告调查了全球骨缝合植入物市场,并提供了市场定义和概述、市场成长影响因素和市场机会分析、市场规模趋势和预测,以及按不同细分市场、地区和主要国家进行的细分、竞争环境及概况。
Global Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
The market for osteosynthesis implants was estimated to be worth USD 5.40 billion in 2023. According to projections, the market for osteosynthesis implants would increase at a compound annual growth rate (CAGR) of 6.11% from USD 5.67 billion in 2024 to USD 9.66 billion by 2032.
The two main drivers propelling the growth of the global osteosynthesis implant market are rising rates of fractures and osteoporosis worldwide. Nonetheless, it is anticipated that the difficulties related to osteosynthesis implants will limit the worldwide market's expansion. However, the market is expected to see profitable prospects due to ongoing clinical trials, increased technology breakthroughs, and an aging population globally.
Decreased bone mass and increased brittleness are the hallmarks of osteoporosis, which presents major problems for fracture care. Fractures are more common in people with osteoporosis, especially in weight-bearing bones like the hip, spine, and wrist. Because the quality of the damaged bone is lower and the mechanical stability is decreased, fractures in osteoporotic bones frequently pose special issues. Because they produce mechanical support and promote fracture healing, osteosynthesis implants are an essential part of the treatment of fractures in patients with osteoporosis.
The need for osteosynthesis implants is rising due to the rising prevalence of osteoporosis worldwide. For example, the International Osteoporosis Foundation stated in 2019 that 500 million men and women worldwide may be impacted by osteoporosis, and that a person breaks a bone owing to the condition every three seconds.
Insights on Market Segments
Based on products, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices, the worldwide osteosynthesis implants are segmented.
Based on material, the osteosynthesis implants market is segmented into categories such as bioabsorbable polymers, titanium and titanium alloys, stainless steel, and others.
Based on the kind of fracture, the osteosynthesis implants market has been divided into segments: hip, knee, spine, shoulder, and others.
Based on the end user, the osteosynthesis implants market has been divided into ambulatory surgical centers, orthopedic clinics, and hospitals.
Area Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. Osteosynthesis implants in North America held the most market share of 39.76% in 2022 and are expected to grow at a compound annual growth rate (CAGR) of 6.33% to reach a projected USD 3.98 billion by 2032. Nonetheless, throughout the course of the projection period, Europe is expected to develop at the highest CAGR of 7.35%.
The market for osteosynthesis implants in North America is expected to develop steadily, and the outlook is still positive. The osteosynthesis implants market is driven by factors such as a high rate of trauma and sports injuries, an increase in orthopedic procedures, and first-rate healthcare infrastructure and services.
The market for osteosynthesis implants in Europe is currently experiencing rapid expansion due to a number of factors, including an increase in sports injuries, an increase in the prevalence of osteoporosis, and a growing patient awareness of the advantages of surgical intervention.
Osteosynthesis implants in Asia-Pacific were valued at USD 0.99 billion in 2022, and during the forecast period, the market is expected to increase at a compound annual growth rate (CAGR) of 5.13%. The Osteosynthesis Implants market for the Rest of the World was valued at USD 0.71 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the forecast period.
Principal Players
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation, and Braun SE are some of the major companies in the osteosynthesis implant market.